These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35479953)
1. Clinical Manifestations and Outcomes of Renal Transplantation Patients With Zou J; Qiu T; Zhou J; Wang T; Ma X; Jin Z; Xu Y; Zhang L; Chen Z Front Med (Lausanne); 2022; 9():860644. PubMed ID: 35479953 [TBL] [Abstract][Full Text] [Related]
2. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia. Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768 [TBL] [Abstract][Full Text] [Related]
3. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation. Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619 [TBL] [Abstract][Full Text] [Related]
4. Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study. Yu Q; Jia P; Su L; Zhao H; Que C BMC Infect Dis; 2017 Jun; 17(1):392. PubMed ID: 28583135 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients. Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337 [TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing. Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171 [TBL] [Abstract][Full Text] [Related]
7. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516 [TBL] [Abstract][Full Text] [Related]
8. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation. Yang P; Zhu X; Liang W; Cai R Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis. Cheng B; Qi C; Zhang S; Wang X Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617 [TBL] [Abstract][Full Text] [Related]
10. Cytomegaloviral or Sun YS; Huang DF; Lin FC; Hsu CK; Sun IT; Chang SC; Tsai CY; Lai CC J Rheumatol; 2019 Mar; 46(3):251-258. PubMed ID: 30504509 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus detection is associated with ICU admission in non-AIDS and AIDS patients with Pneumocystis jirovecii pneumonia. Perret A; Le Marechal M; Germi R; Maubon D; Garnaud C; Noble J; Boignard A; Falque L; Meunier M; Gerster T; Epaulard O PLoS One; 2024; 19(1):e0296758. PubMed ID: 38198473 [TBL] [Abstract][Full Text] [Related]
12. Clinical descriptive analysis of severe Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387 [No Abstract] [Full Text] [Related]
13. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients. Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744 [TBL] [Abstract][Full Text] [Related]
14. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients. Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. Lee SH; Huh KH; Joo DJ; Kim MS; Kim SI; Lee J; Park MS; Kim YS; Kim SK; Chang J; Kim YS; Kim SY Sci Rep; 2017 May; 7(1):1571. PubMed ID: 28484270 [TBL] [Abstract][Full Text] [Related]
16. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients. Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544 [TBL] [Abstract][Full Text] [Related]
18. [Clinical features and death risk factors of pneumocystis jirovecii pneumonia in kidney disease patients with immunosuppressive therapy]. Shen C; Xu R Zhonghua Yu Fang Yi Xue Za Zhi; 2024 May; 58(5):673-678. PubMed ID: 38715508 [TBL] [Abstract][Full Text] [Related]
19. A Rare Case of Ulcerative Colitis with Severe Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review. Watanabe Y; Hayashi K; Terai S Intern Med; 2022 Feb; 61(3):339-344. PubMed ID: 34373380 [TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort. Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C; Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]